Lorraine Colón-Cartagena, MD
she/her/hers
Assistant Professor of PathologyCards
About
Research
Publications
2026
Lessons Learned From 26 Adenomyoepitheliomas of the Breast.
Colón Cartagena L, Perera N, Liang Y, Zhan H, Krishnamurti U. Lessons Learned From 26 Adenomyoepitheliomas of the Breast. The American Journal Of Surgical Pathology 2026 PMID: 42676113, DOI: 10.1097/pas.0000000000002598.Peer-Reviewed Original ResearchPathologic Characterization of Non-Mass Enhancement Lesions of the Breast in MRI-guided Biopsy
Jordan T, Liang Y, Colón Cartagena L, Buza N, Krishnamurti U, Zhan H. Pathologic Characterization of Non-Mass Enhancement Lesions of the Breast in MRI-guided Biopsy. Human Pathology 2026, 106220. PMID: 42556743, DOI: 10.1016/j.humpath.2026.106220.Peer-Reviewed Original ResearchHistomorphologic analysis and clinical correlation of atypical apocrine lesions in breast pathology
Podany P, Zhan H, Colón-Cartagena L, Ai D, Du J, Krishnamurti U, Liang Y. Histomorphologic analysis and clinical correlation of atypical apocrine lesions in breast pathology. Human Pathology 2026, 175: 106158. PMID: 42176994, DOI: 10.1016/j.humpath.2026.106158.Peer-Reviewed Original ResearchDiagnosis of Ductal Carcinoma in Situ in Breast Biopsies for a Radiological Mass Lesion: Did We Miss Something?
Theriot J, Zhan H, Colón-Cartagena L, Lotfi P, Krishnamurti U, Liang Y. Diagnosis of Ductal Carcinoma in Situ in Breast Biopsies for a Radiological Mass Lesion: Did We Miss Something? International Journal Of Surgical Pathology 2026, 34: 1446-1451. PMID: 41944434, DOI: 10.1177/10668969261436010.Peer-Reviewed Original ResearchQuantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score
He M, Chan N, Liu M, Robbins C, Bates K, Benanto J, Colón-Cartagena L, Kahila M, Zhan H, Krishnamurti U, Moutafi M, Yaghoobi V, Liebler D, Fulton R, Rimm D. Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score. Applied Immunohistochemistry & Molecular Morphology 2026, 34: 143-154. PMID: 41709478, PMCID: PMC13143368, DOI: 10.1097/pai.0000000000001311.Peer-Reviewed Original Research
2025
Interobserver agreement and histologic analysis of atypical ductal hyperplasia bordering on ductal carcinoma in situ: A multi-institutional study
Korie U, Ai D, Podany P, Zhang H, Zhan H, Kahila M, Colon-Cartagena L, Wei S, Sun H, Du J, Krishnamurti U, Liang Y. Interobserver agreement and histologic analysis of atypical ductal hyperplasia bordering on ductal carcinoma in situ: A multi-institutional study. American Journal Of Clinical Pathology 2025, 164: 704-711. PMID: 40994034, DOI: 10.1093/ajcp/aqaf088.Peer-Reviewed Original Research
2024
A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms
Pareja F, Dopeso H, Wang Y, Gazzo A, Brown D, Banerjee M, Selenica P, Bernhard J, Derakhshan F, da Silva E, Colon-Cartagena L, Basili T, Marra A, Sue J, Ye Q, Da Cruz Paula A, Yildirim S, Pei X, Safonov A, Green H, Gill K, Zhu Y, Lee M, Godrich R, Casson A, Weigelt B, Riaz N, Wen H, Brogi E, Mandelker D, Hanna M, Kunz J, Rothrock B, Chandarlapaty S, Kanan C, Oakley J, Klimstra D, Fuchs T, Reis-Filho J. A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms. Cancer Research 2024, 84: 3478-3489. PMID: 39106449, PMCID: PMC11479818, DOI: 10.1158/0008-5472.can-24-1322.Peer-Reviewed Original ResearchGenomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations
Dopeso H, Gazzo A, Derakhshan F, Brown D, Selenica P, Jalali S, Da Cruz Paula A, Marra A, da Silva E, Basili T, Gusain L, Colon-Cartagena L, Bhaloo S, Green H, Vanderbilt C, Oesterreich S, Grabenstetter A, Kuba M, Ross D, Giri D, Wen H, Zhang H, Brogi E, Weigelt B, Pareja F, Reis-Filho J. Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations. Npj Precision Oncology 2024, 8: 33. PMID: 38347189, PMCID: PMC10861500, DOI: 10.1038/s41698-024-00508-x.Peer-Reviewed Original Research
2021
Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β
Pradhan A, Maji S, Bhoopathi P, Talukdar S, Mannangatti P, Guo C, Wang X, Cartagena L, Idowu M, Landry J, Sarkar D, Emdad L, Cavenee W, Das S, Fisher P. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β. Proceedings Of The National Academy Of Sciences Of The United States Of America 2021, 118: e2103180118. PMID: 34016751, PMCID: PMC8166168, DOI: 10.1073/pnas.2103180118.Peer-Reviewed Original ResearchAnimalsAntineoplastic AgentsBreast NeoplasmsCell Line, TumorChemokine CCL11Chemokine CCL17FemaleGene Expression Regulation, NeoplasticHumansInterleukin-10Interleukin-1alphaInterleukin-1betaInterleukin-23 Subunit p19Interleukin-5Lung NeoplasmsMiceMice, Inbred BALB COxadiazolesPyrimidinesSignal TransductionSynteninsT-Lymphocytes, CytotoxicTumor BurdenXenograft Model Antitumor AssaysBreast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization
Cartagena L, McGuire K, Zot P, Pillappa R, Idowu M, Robila V. Breast-Conserving Surgeries With and Without Cavity Shave Margins Have Different Re-excision Rates and Associated Overall Cost: Institutional and Patient-Driven Decisions for Its Utilization. Clinical Breast Cancer 2021, 21: e594-e601. PMID: 33814286, DOI: 10.1016/j.clbc.2021.03.003.Peer-Reviewed Original Research
News
News
- September 24, 2026
Study Informs How to Diagnose Underrecognized Breast Tumor
- August 25, 2026
Colón-Cartagena Named New Director of Digital Pathology
- March 27, 2025
Yale Pathologists Share Insight, Latest Research at USCAP 2025
Get In Touch
Contacts
Email